Details
Category: Volume 07 Issue 07 July 2019
Hits: 1168

Title: A Comparative Study between two different HDR Fractionation schedules of Intracavitary Brachytherapy in Carcinoma Cervix Stage-III

Authors: Dr Atul Tiwari, Dr Atul Verma, Dr Neeti Sharma, Dr H.S.Kumar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.115

Abstract

Aim: To compare and analysis two high-dose-rate intracavitary brachytherapy schedule of 7.5Gy per fraction per for 3 fractions over 6Gy per fraction for 4 fractions in the treatment of carcinoma of uterine cervix.

Materials and Methods: Total 50 patients with carcinoma of the uterine cervix (Stages III) were treated with External Beam Radiotherapy (EBRT) and High Dose Rate Intracavitary Brachytherapy (HDR- ICBT). These were randomized to arm A- 6 Gy per fraction for 4 fractions and arm B – 7.5Gy per fraction for 3 fractions. In both Arms 25 patients were included, out of those 1 patient from Arm Blost during follow up.Then follow up was done after 1yr, 2yr & 3yr to evaluate the Local control rate, disease-free survival and overall survival.

Results: The median follow-up period in the study was 22 months for Arm A and 21 months for Arm B. In the Control Arm A, Local control rate, disease-free survival and overall survival were 84%, 84%and 92 %, respectively, while in the Study Arm B, were 87.50%, 87.50% and  91.66%, respectively (p value >0.05).

Conclusion: In Indian context  taking into account of increased hospital burden of locally advanced cancer cervix patients, HDR intracavitary brachytherapy schedule of 7.5 Gy per fraction 3 fractions is the preferable option over 6 Gy per fraction 4 fractions with regard to comparable, acute and late toxicity, loco-regional control, disease free survival and better patients compliance to lesser fractionation schedule.

Keywords: External beam radiotherapy, Gynecological malignancy, latetoxicity, ICBT _ 6Gy per fraction _ 7.5Gy per fraction.

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E. Global cancer statistics, CA: A [1] Cancer Journal for Clinicians. 2011; 61:69–90.
  2. Nag S, Orton C, Petereit D. The American brachytherapy society recommendations for hdr brachytherapy of the cervix. Int J Radiat Oncol Biol Phys. 2000; 48:201–11.
  3. Viswanathan A, Creutzberg C, Craighead P. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys. 2012; 82:250–55.
  4. Fowler JF. The radiobiology of brachytherapy. In: Martinez AA, Orton GC, Mould RF, editors. Brachytherapy HDR and LDR. Columbia, SC: Nucletron Corporation; 1990. Pp. 121-37.
  5. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105:103-04.
  6. International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda, MD: Author, 1985.4-5.
  7. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45:228-47.
  8. Cox JF, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31:1341-46.
  9. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457–81.
  10. Orton GC, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote after loading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 1991; 21:1425-34.
  11. Orton GC. Width of the therapeutic window: What is the optimaldose-per- fraction for high dose rate cervix cancer brachytherapy? Int J Radiat Oncol Biol Phys. 1995; 31:1011-13.
  12. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys. 1999; 43:359-66.
  13. Okkan S, Atkovar G, Sahinler I, Oner Dinçbaş F, Koca A, Köksal S, et al. Results and complications of high dose rate and low dose ratebrachytherapy in carcinoma of the cervix: Cerrahpaşa experience. Radiother Oncol. 2003; 67:97105.
  14. Azad SK, Choudhary V. Treatment results of radical radiotherapy of carcinoma uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy. J Cancer Res Ther. 2010; 6:482-86.
  15. Patidar AK, Kumar HS, Walke RV, Hirapara Pushpendra H, Lal JS, Bardia MR. Evaluation of the response of concurrent high dose rate intracavitary brachytherapy with external beam radiotherapy in management of early stage carcinoma cervix. J Obstet Gynaecol India. 2012; 6:562-65.
  16. Tharavichitkul E, Klunkin P, Lorvidhaya V, Sukthomya V, Chakrabhandu S, Pukanhaphan N, et al. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand. J Radiat Res. 2012; 53:281-87.
  17. Huang EY, Sun LM, Lin H, Lan JH, Chanchien CC, Huang YJ, et al. Prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brach therapy (HDR-ICBT) in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013; 85:123-28.
  18. Einck JP, Hudson A, Shulman AC, Yashar CM, Dieng MM, Diagne M, et al Implementation of a high-dose-rate brachytherapy program for carcinoma of the  cervix in Senegal: a pragmatic model for the developing world. Int J Radiat Oncol Biol Phys. 2014; 89:462-67.
  19. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys. 2001; 50:1123-35.
  20. Toita T, Kakinohana Y, Ogawa K, Adachi G, Moromizato H, Nagai Y, et al. Combination external beam radiotherapy and high-dose rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys. 2003; 56:1344-53.
  21. Clark BG, Souhami L, Roman TN, Chappell R, Evans MD, Fowler JF. The prediction of late rectal complications in patients treated with high doserate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1997; 38:989-93.
  22. Ogino I, Kitamura T, Okamoto N, Yamasita K, Aikawa Y, Okajima H, et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys. 1995; 31:725-34.
  23. Patel FD, Kumar P, Karunanidhi G, Sharma SC, Kapoor R. Optimization of high- dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix. Brachytherapy. 2011; 10:147-53.

Corresponding Author

Dr Atul Verma

Medical Officer, Radiation Oncology Department, RNT Medical College, Udaipur, India